Literature DB >> 20558564

Renal transplantation in familial dysautonomia: report of two cases and review of the literature.

Yelena Rekhtman1, Andrew S Bomback, Martin A Nash, Scott D Cohen, Albert Matalon, Dominique M Jan, Horacio Kaufmann, Felicia B Axelrod, Jai Radhakrishnan, Gerald B Appel.   

Abstract

BACKGROUND AND OBJECTIVES: Chronic kidney disease (CKD) is an increasingly recognized complication of familial dysautonomia (FD), a neurodevelopmental disorder with protean systemic manifestations that are the result of sensory and autonomic dysfunction. Progressive renal dysfunction occurs due to chronic volume depletion and cardiovascular lability with supine hypertension and orthostatic hypotension. By age 25, nearly one-half of all patients with FD will have reached stage 3 CKD. Furthermore, dialysis for ESRD in FD patients is associated with multiple complications and poor outcomes. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: We report two patients with FD who developed ESRD at ages 27 and 16, respectively, and underwent renal transplantation. Transplant was performed after 3 months on intermittent hemodialysis (HD) in the first case and after 1 month on twice-weekly continuous veno-venous hemodialysis (CVVHD) in the second case.
RESULTS: Both patients tolerated surgery well and have maintained good graft function at 20 and 24 months posttransplantation, respectively. Symptomatic and functional improvements have included lower supine BP and increased sensitivity to antihypertensive agents.
CONCLUSIONS: As general supportive care improves the lifespan of FD patients, issues related to the management of ESRD will become more important. Renal transplantation provides a viable alternative to dialysis for FD patients with ESRD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558564      PMCID: PMC2974411          DOI: 10.2215/CJN.01750210

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  19 in total

1.  Survival in familial dysautonomia: Impact of early intervention.

Authors:  Felicia B Axelrod; Judith D Goldberg; Xiang Y Ye; Channa Maayan
Journal:  J Pediatr       Date:  2002-10       Impact factor: 4.406

2.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia.

Authors:  S A Slaugenhaupt; A Blumenfeld; S P Gill; M Leyne; J Mull; M P Cuajungco; C B Liebert; B Chadwick; M Idelson; L Reznik; C Robbins; I Makalowska; M Brownstein; D Krappmann; C Scheidereit; C Maayan; F B Axelrod; J F Gusella
Journal:  Am J Hum Genet       Date:  2001-01-22       Impact factor: 11.025

3.  Deficient sympathetic nervous response in familial dysautonomia.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  N Engl J Med       Date:  1976-03-18       Impact factor: 91.245

4.  The effects of postural change and exercise on renal haemodynamics in familial dysautonomia.

Authors:  F B Axelrod; J S Glickstein; J Weider; M C Gluck; D Friedman
Journal:  Clin Auton Res       Date:  1993-06       Impact factor: 4.435

5.  Anesthetic management of renal transplantation in a patient with familial dysautonomia.

Authors:  Gen Koshibe; H Thomas Lee
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

6.  Renal disease in familial dysautonomia.

Authors:  J Pearson; G Gallo; M Gluck; F Axelrod
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

7.  Familial dysautonomia: detection of the IKBKAP IVS20(+6T --> C) and R696P mutations and frequencies among Ashkenazi Jews.

Authors:  Jianli Dong; Lisa Edelmann; Asghar M Bajwa; Ruth Kornreich; Robert J Desnick
Journal:  Am J Med Genet       Date:  2002-07-01

8.  Dermal microdialysis provides evidence for hypersensitivity to noradrenaline in patients with familial dysautonomia.

Authors:  A Bickel; F B Axelrod; M Schmelz; H Marthol; M J Hilz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

9.  Fundoplication and gastrostomy in familial dysautonomia.

Authors:  F B Axelrod; T H Gouge; H B Ginsburg; B S Bangaru; C Hazzi
Journal:  J Pediatr       Date:  1991-03       Impact factor: 4.406

Review 10.  Familial dysautonomia.

Authors:  Felicia B Axelrod
Journal:  Muscle Nerve       Date:  2004-03       Impact factor: 3.217

View more
  8 in total

Review 1.  Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.

Authors:  Coreen Schwartzlow; Mohamed Kazamel
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-20       Impact factor: 5.081

Review 2.  Current treatments in familial dysautonomia.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Cristina Fuente-Mora; Leila Percival; Carlos Mendoza-Santiesteban; Horacio Kaufmann
Journal:  Expert Opin Pharmacother       Date:  2014-10-17       Impact factor: 3.889

3.  Blood pressure instability in head and neck cancer survivors.

Authors:  Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Clin Auton Res       Date:  2020-07-20       Impact factor: 4.435

4.  IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia.

Authors:  Paula Dietrich; Shanta Alli; Revathi Shanmugasundaram; Ioannis Dragatsis
Journal:  Hum Mol Genet       Date:  2012-08-24       Impact factor: 6.150

5.  Carbidopa for Afferent Baroreflex Failure in Familial Dysautonomia: A Double-Blind Randomized Crossover Clinical Trial.

Authors:  Lucy Norcliffe-Kaufmann; Jose-Alberto Palma; Jose Martinez; Horacio Kaufmann
Journal:  Hypertension       Date:  2020-07-13       Impact factor: 10.190

6.  Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome.

Authors:  L Norcliffe-Kaufmann; F B Axelrod; H Kaufmann
Journal:  J Hum Hypertens       Date:  2011-12-01       Impact factor: 3.012

7.  Novel RETREG1 (FAM134B) founder allele is linked to HSAN2B and renal disease in a Turkish family.

Authors:  Elifcan Taşdelen; Daniel G Calame; Gulsen Akay; Tadahiro Mitani; Jawid M Fatih; Isabella Herman; Haowei Du; Zeynep Coban-Akdemir; Dana Marafi; Shalini N Jhangiani; Jennifer E Posey; Richard A Gibbs; Taylan Altıparmak; Nüket Yürür Kutlay; James R Lupski; Davut Pehlivan
Journal:  Am J Med Genet A       Date:  2022-03-24       Impact factor: 2.578

8.  Renal Transplantation in Pure Autonomic Failure.

Authors:  Zain Ul Abideen; Anna Rixon; Nirosha D Gunatillake; Elizabeth Househam; Christopher J Mathias; Andrew Connor
Journal:  Transplant Direct       Date:  2022-08-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.